PXD021592-1
PXD021592 is an original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Discovery of a degrader for AML differentiation therapy |
| Description | NB4 cells were treated with the 250 nM RPOTAC molecule CPS2 for 6 h before cell lysis. CDK2 stood out as the most down-regulated target.Quantitative analysis of the cells after treatment. |
| HostingRepository | iProX |
| AnnounceDate | 2020-09-21 |
| AnnouncementXML | Submission_2020-10-07_01:05:21.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Liguo Wang |
| SpeciesList | scientific name: Homo sapiens; NCBI TaxID: 9606; |
| ModificationList | TMT6plex reporter fragment |
| Instrument | Orbitrap Fusion |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
|---|---|---|---|
| 0 | 2020-09-21 06:34:36 | ID requested | |
| ⏵ 1 | 2020-10-07 01:05:21 | announced |
Publication List
| Dataset with its publication pending |
Keyword List
| submitter keyword: CDK differentiation degrader |
Contact List
| Yu Rao | |
|---|---|
| contact affiliation | Tsinghua University |
| contact email | yrao@mail.tsinghua.edu.cn |
| lab head | |
| Liguo Wang | |
| contact affiliation | Tsinghua University |
| contact email | wangl.g@foxmail.com |
| dataset submitter | |
Full Dataset Link List
| iProX dataset URI |




